Expression of the plasminogen activator system in the human vascular wall

Atherosclerosis

Volumn 152, Issue 1, 2000, Pages 19-28

  Salame, M Y ^a   Samani, N J ^a   Masood, I ^a   Debono, D P ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; PAI 1; Plasminogen activator; Saphenous veins; Urokinase type plasminogen activator (uPA); Urokinase type plasminogen activator (uPA) receptor

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; ATHERECTOMY; ATHEROMA; BLOOD VESSEL WALL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERNAL MAMMARY ARTERY; INTIMA; MACROPHAGE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SAPHENOUS VEIN GRAFT; VASCULAR ENDOTHELIUM;

ARTERIOSCLEROSIS; BASE SEQUENCE; BLOOD VESSELS; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MOLECULAR SEQUENCE DATA; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; PROBABILITY; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; SUPPORT, NON-U.S. GOV'T; TISSUE CULTURE; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0034283523     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00441-4     Document Type: Article

References (20)

1. Astrup T. The biological significance of fibrinolysis. Lancet. 25:1956;569.
2. Todd A.S. Histological localisation of plasminogen activator. J. Pathol. Bacteriol. 78:1959;281-287.
3. Kwaan H.C., Astrup T. Fibrinolytic activity in human atherosclerotic coronary arteries. Circ. Res. 21:1967;799-804.
4. Lupu F., Heim D.A., Bachmann F., Hurni M., Kakkar W., Kruithof E.K.O. Plasminogen activator expression in human advanced atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 15:1995;1444-1455.
5. Robbie L.A., Booth N.A., Brown A.J., Bennett B. Inhibitors of fibrinolysis are elevated in atherosclerotic plaque. Arterioscler. Thromb. Vasc. Biol. 16:1996;539-545.
6. Clowes A.W., Clowes M.M., Au Y.P.T., Reidy M.A., Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ. Res. 67:1990;61-67.
7. Jackson C.L., Reidy M.A. The role of plasminogen activation in smooth muscle migration after arterial injury. Ann. N.Y. Acad. Sci. 667:1992;141-150.
8. More R.S., Underwood M.J., Brack M.J., deBono D.P., Gershlick A.H. Changes in vessel wall plasminogen activator activity and smooth muscle cell proliferation and activation after arterial injury. Cardiovasc. Res. 29:1995;22-26.
9. Underwood M.J., deBono D.P. Increased fibrinolytic activity in the intima of atheromatous coronary arteries: protection at a price. Cardiovasc. Res. 27:1993;882-885.
10. Lee R.T., Libby P. The unstable atheroma. Arterioscler. Thromb. Vasc. Biol. 17:1997;1859-1867.
11. Felton C.V., Crook D., Davies M.J., Oliver M.F. Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Arterioscler. Thromb. Vasc. Biol. 17:1997;1337-1345.
12. Schneiderman J., Sawdrey M.S., Keeton M.R., Bordin G.M., Bernstein E.F., Dilley R.B., Loskutoff D. Increased plasminogen activator inhibitor type 1 gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. USA. 89:1992;6998-7002.
13. Grancha S., Estelles A., Falco C., Chirivella M., Espana F., Aznar J. Detailed localization of type-1 plasminogen activator inhibitor mRNA expression and antigen in atherosclerotic plaque on human coronary artery. Fibrinolysis Proteolysis. 12:1998;53-60.
14. Carmeliet P., Moons L., Herbert J.M., Lupu F., Lijuen R., Collen D. Urokinase- but not tissue-type plasminogen activators mediate arterial neointima formation in mice. Circ. Res. 81:1997;829-839.
15. Carmeliet P., Moons L., Lijnen R., Janssens S., Lupu F., Collen D., Gerard R.D. Role of plasminogen activator inhibitor-1 in vascular wound healing and arterial neointima formation. A gene targeting and gene transfer study in mice. Circulation. 96:1997;3180-3191.
16. Chomczynski P., Sacchi N. Single-step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
17. Bergsdorf N., Nilsson T., Wallen P. An enzyme linked immunosorbent assay for determination of tissue plasminogen activator applied to patients with thromboembolic disease. Thromb. Haemost. 50:(3):1983;740-744.
18. Carmeliet P., Collen D. Role of plasminogen/plasmin system in thrombosis, hemostasis, restenosis and atherosclerosis evaluation in transgenic animals. Trends Cardiovasc. Med. 5:1995;117-122.
19. Lijnen R.H., Van Hoef B., Lupu F., Moons L., Carmeliet P., Collen D. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler. Thromb. Vasc. Biol. 18:1998;1035-1045.
20. Loskutoff D.J. Regulation of PAI-1 gene expression. Fibrinolysis. 5:1991;197-206.